 | • レポートコード：MRC2Q12-02445 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、医療用バイオプラスチックのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 医療用バイオプラスチックのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 医療用バイオプラスチックの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 医療用バイオプラスチックのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの医療用バイオプラスチックの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の医療用バイオプラスチックの売上および2028年までの予測に焦点を当てています。 医療用バイオプラスチックのグローバル主要企業には、BASF、Mitsubishi Chemical、Eastman、Futamura Group、Neste、TotalEnergies Corbion、NatureWorks、BD、Bormioli Pharma、Biome Bioplastics、Novamont、DSM、Braskemなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 医療用バイオプラスチック市場は、タイプとアプリケーションによって区分されます。世界の医療用バイオプラスチック市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 バイオPE、再生セルロース、ポリヒドロキシアルコノエート、ポリ乳酸（PLA）、その他 【アプリケーション別セグメント】 創傷管理、ドラッグデリバリー、整形外科器具、繊維・多孔質足場、医薬品包装、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 医療用バイオプラスチック製品概要 - タイプ別市場（バイオPE、再生セルロース、ポリヒドロキシアルコノエート、ポリ乳酸（PLA）、その他） - アプリケーション別市場（創傷管理、ドラッグデリバリー、整形外科器具、繊維・多孔質足場、医薬品包装、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の医療用バイオプラスチック販売量予測2017-2028 - 世界の医療用バイオプラスチック売上予測2017-2028 - 医療用バイオプラスチックの地域別販売量 - 医療用バイオプラスチックの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別医療用バイオプラスチック販売量 - 主要メーカー別医療用バイオプラスチック売上 - 主要メーカー別医療用バイオプラスチック価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（バイオPE、再生セルロース、ポリヒドロキシアルコノエート、ポリ乳酸（PLA）、その他） - 医療用バイオプラスチックのタイプ別販売量 - 医療用バイオプラスチックのタイプ別売上 - 医療用バイオプラスチックのタイプ別価格 ・アプリケーション別市場規模（創傷管理、ドラッグデリバリー、整形外科器具、繊維・多孔質足場、医薬品包装、その他） - 医療用バイオプラスチックのアプリケーション別販売量 - 医療用バイオプラスチックのアプリケーション別売上 - 医療用バイオプラスチックのアプリケーション別価格 ・北米市場 - 北米の医療用バイオプラスチック市場規模（タイプ別、アプリケーション別） - 主要国別の医療用バイオプラスチック市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの医療用バイオプラスチック市場規模（タイプ別、アプリケーション別） - 主要国別の医療用バイオプラスチック市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の医療用バイオプラスチック市場規模（タイプ別、アプリケーション別） - 主要国別の医療用バイオプラスチック市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の医療用バイオプラスチック市場規模（タイプ別、アプリケーション別） - 主要国別の医療用バイオプラスチック市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの医療用バイオプラスチック市場規模（タイプ別、アプリケーション別） - 主要国別の医療用バイオプラスチック市場規模（トルコ、サウジアラビア） ・企業情報 BASF、Mitsubishi Chemical、Eastman、Futamura Group、Neste、TotalEnergies Corbion、NatureWorks、BD、Bormioli Pharma、Biome Bioplastics、Novamont、DSM、Braskem ・産業チェーン及び販売チャネル分析 - 医療用バイオプラスチックの産業チェーン分析 - 医療用バイオプラスチックの原材料 - 医療用バイオプラスチックの生産プロセス - 医療用バイオプラスチックの販売及びマーケティング - 医療用バイオプラスチックの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 医療用バイオプラスチックの産業動向 - 医療用バイオプラスチックのマーケットドライバー - 医療用バイオプラスチックの課題 - 医療用バイオプラスチックの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Medical Bioplastic estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Medical Bioplastic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Medical Bioplastic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Medical Bioplastic is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Medical Bioplastic include BASF, Mitsubishi Chemical, Eastman, Futamura Group, Neste, TotalEnergies Corbion, NatureWorks, BD and Bormioli Pharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Medical Bioplastic production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Medical Bioplastic by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Medical Bioplastic manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Medical Bioplastic market. Further, it explains the major drivers and regional dynamics of the global Medical Bioplastic market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
BASF
Mitsubishi Chemical
Eastman
Futamura Group
Neste
TotalEnergies Corbion
NatureWorks
BD
Bormioli Pharma
Biome Bioplastics
Novamont
DSM
Braskem
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Medical Bioplastic Segment by Type
Bio-PE
Regenerated Cellulose
Poly Hydroxyalkonoates
Polylactic Acid (PLA)
Others
Medical Bioplastic Segment by Application
Wound Management
Drug Delivery
Orthopedic Instruments
Fiber And Porous Scaffolds
Pharmaceutical Packaging
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Medical Bioplastic production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Medical Bioplastic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Medical Bioplastic, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Medical Bioplastic, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Medical Bioplastic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medical Bioplastic sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Medical Bioplastic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Medical Bioplastic sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BASF, Mitsubishi Chemical, Eastman, Futamura Group, Neste, TotalEnergies Corbion, NatureWorks, BD and Bormioli Pharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Medical Bioplastic capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Medical Bioplastic in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Medical Bioplastic manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Bioplastic sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Medical Bioplastic Product Introduction
1.2 Market by Type
1.2.1 Global Medical Bioplastic Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Bio-PE
1.2.3 Regenerated Cellulose
1.2.4 Poly Hydroxyalkonoates
1.2.5 Polylactic Acid (PLA)
1.2.6 Others
1.3 Market by Application
1.3.1 Global Medical Bioplastic Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Wound Management
1.3.3 Drug Delivery
1.3.4 Orthopedic Instruments
1.3.5 Fiber And Porous Scaffolds
1.3.6 Pharmaceutical Packaging
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Medical Bioplastic Production
2.1 Global Medical Bioplastic Production Capacity (2017-2028)
2.2 Global Medical Bioplastic Production by Region: 2017 VS 2021 VS 2028
2.3 Global Medical Bioplastic Production by Region
2.3.1 Global Medical Bioplastic Historic Production by Region (2017-2022)
2.3.2 Global Medical Bioplastic Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Medical Bioplastic Sales in Volume & Value Estimates and Forecasts
3.1 Global Medical Bioplastic Sales Estimates and Forecasts 2017-2028
3.2 Global Medical Bioplastic Revenue Estimates and Forecasts 2017-2028
3.3 Global Medical Bioplastic Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Medical Bioplastic Sales by Region
3.4.1 Global Medical Bioplastic Sales by Region (2017-2022)
3.4.2 Global Sales Medical Bioplastic by Region (2023-2028)
3.5 Global Medical Bioplastic Revenue by Region
3.5.1 Global Medical Bioplastic Revenue by Region (2017-2022)
3.5.2 Global Medical Bioplastic Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Medical Bioplastic Production Capacity by Manufacturers
4.2 Global Medical Bioplastic Sales by Manufacturers
4.2.1 Global Medical Bioplastic Sales by Manufacturers (2017-2022)
4.2.2 Global Medical Bioplastic Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Bioplastic in 2021
4.3 Global Medical Bioplastic Revenue by Manufacturers
4.3.1 Global Medical Bioplastic Revenue by Manufacturers (2017-2022)
4.3.2 Global Medical Bioplastic Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Medical Bioplastic Revenue in 2021
4.4 Global Medical Bioplastic Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Medical Bioplastic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Medical Bioplastic Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Medical Bioplastic Sales by Type
5.1.1 Global Medical Bioplastic Historical Sales by Type (2017-2022)
5.1.2 Global Medical Bioplastic Forecasted Sales by Type (2023-2028)
5.1.3 Global Medical Bioplastic Sales Market Share by Type (2017-2028)
5.2 Global Medical Bioplastic Revenue by Type
5.2.1 Global Medical Bioplastic Historical Revenue by Type (2017-2022)
5.2.2 Global Medical Bioplastic Forecasted Revenue by Type (2023-2028)
5.2.3 Global Medical Bioplastic Revenue Market Share by Type (2017-2028)
5.3 Global Medical Bioplastic Price by Type
5.3.1 Global Medical Bioplastic Price by Type (2017-2022)
5.3.2 Global Medical Bioplastic Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Medical Bioplastic Sales by Application
6.1.1 Global Medical Bioplastic Historical Sales by Application (2017-2022)
6.1.2 Global Medical Bioplastic Forecasted Sales by Application (2023-2028)
6.1.3 Global Medical Bioplastic Sales Market Share by Application (2017-2028)
6.2 Global Medical Bioplastic Revenue by Application
6.2.1 Global Medical Bioplastic Historical Revenue by Application (2017-2022)
6.2.2 Global Medical Bioplastic Forecasted Revenue by Application (2023-2028)
6.2.3 Global Medical Bioplastic Revenue Market Share by Application (2017-2028)
6.3 Global Medical Bioplastic Price by Application
6.3.1 Global Medical Bioplastic Price by Application (2017-2022)
6.3.2 Global Medical Bioplastic Price Forecast by Application (2023-2028)
7 North America
7.1 North America Medical Bioplastic Market Size by Type
7.1.1 North America Medical Bioplastic Sales by Type (2017-2028)
7.1.2 North America Medical Bioplastic Revenue by Type (2017-2028)
7.2 North America Medical Bioplastic Market Size by Application
7.2.1 North America Medical Bioplastic Sales by Application (2017-2028)
7.2.2 North America Medical Bioplastic Revenue by Application (2017-2028)
7.3 North America Medical Bioplastic Sales by Country
7.3.1 North America Medical Bioplastic Sales by Country (2017-2028)
7.3.2 North America Medical Bioplastic Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Medical Bioplastic Market Size by Type
8.1.1 Europe Medical Bioplastic Sales by Type (2017-2028)
8.1.2 Europe Medical Bioplastic Revenue by Type (2017-2028)
8.2 Europe Medical Bioplastic Market Size by Application
8.2.1 Europe Medical Bioplastic Sales by Application (2017-2028)
8.2.2 Europe Medical Bioplastic Revenue by Application (2017-2028)
8.3 Europe Medical Bioplastic Sales by Country
8.3.1 Europe Medical Bioplastic Sales by Country (2017-2028)
8.3.2 Europe Medical Bioplastic Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Medical Bioplastic Market Size by Type
9.1.1 Asia Pacific Medical Bioplastic Sales by Type (2017-2028)
9.1.2 Asia Pacific Medical Bioplastic Revenue by Type (2017-2028)
9.2 Asia Pacific Medical Bioplastic Market Size by Application
9.2.1 Asia Pacific Medical Bioplastic Sales by Application (2017-2028)
9.2.2 Asia Pacific Medical Bioplastic Revenue by Application (2017-2028)
9.3 Asia Pacific Medical Bioplastic Sales by Region
9.3.1 Asia Pacific Medical Bioplastic Sales by Region (2017-2028)
9.3.2 Asia Pacific Medical Bioplastic Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Medical Bioplastic Market Size by Type
10.1.1 Latin America Medical Bioplastic Sales by Type (2017-2028)
10.1.2 Latin America Medical Bioplastic Revenue by Type (2017-2028)
10.2 Latin America Medical Bioplastic Market Size by Application
10.2.1 Latin America Medical Bioplastic Sales by Application (2017-2028)
10.2.2 Latin America Medical Bioplastic Revenue by Application (2017-2028)
10.3 Latin America Medical Bioplastic Sales by Country
10.3.1 Latin America Medical Bioplastic Sales by Country (2017-2028)
10.3.2 Latin America Medical Bioplastic Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Medical Bioplastic Market Size by Type
11.1.1 Middle East and Africa Medical Bioplastic Sales by Type (2017-2028)
11.1.2 Middle East and Africa Medical Bioplastic Revenue by Type (2017-2028)
11.2 Middle East and Africa Medical Bioplastic Market Size by Application
11.2.1 Middle East and Africa Medical Bioplastic Sales by Application (2017-2028)
11.2.2 Middle East and Africa Medical Bioplastic Revenue by Application (2017-2028)
11.3 Middle East and Africa Medical Bioplastic Sales by Country
11.3.1 Middle East and Africa Medical Bioplastic Sales by Country (2017-2028)
11.3.2 Middle East and Africa Medical Bioplastic Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 BASF
12.1.1 BASF Corporation Information
12.1.2 BASF Overview
12.1.3 BASF Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 BASF Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 BASF Recent Developments
12.2 Mitsubishi Chemical
12.2.1 Mitsubishi Chemical Corporation Information
12.2.2 Mitsubishi Chemical Overview
12.2.3 Mitsubishi Chemical Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Mitsubishi Chemical Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Mitsubishi Chemical Recent Developments
12.3 Eastman
12.3.1 Eastman Corporation Information
12.3.2 Eastman Overview
12.3.3 Eastman Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Eastman Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Eastman Recent Developments
12.4 Futamura Group
12.4.1 Futamura Group Corporation Information
12.4.2 Futamura Group Overview
12.4.3 Futamura Group Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Futamura Group Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Futamura Group Recent Developments
12.5 Neste
12.5.1 Neste Corporation Information
12.5.2 Neste Overview
12.5.3 Neste Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Neste Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Neste Recent Developments
12.6 TotalEnergies Corbion
12.6.1 TotalEnergies Corbion Corporation Information
12.6.2 TotalEnergies Corbion Overview
12.6.3 TotalEnergies Corbion Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 TotalEnergies Corbion Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 TotalEnergies Corbion Recent Developments
12.7 NatureWorks
12.7.1 NatureWorks Corporation Information
12.7.2 NatureWorks Overview
12.7.3 NatureWorks Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 NatureWorks Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 NatureWorks Recent Developments
12.8 BD
12.8.1 BD Corporation Information
12.8.2 BD Overview
12.8.3 BD Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 BD Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 BD Recent Developments
12.9 Bormioli Pharma
12.9.1 Bormioli Pharma Corporation Information
12.9.2 Bormioli Pharma Overview
12.9.3 Bormioli Pharma Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Bormioli Pharma Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Bormioli Pharma Recent Developments
12.10 Biome Bioplastics
12.10.1 Biome Bioplastics Corporation Information
12.10.2 Biome Bioplastics Overview
12.10.3 Biome Bioplastics Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Biome Bioplastics Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Biome Bioplastics Recent Developments
12.11 Novamont
12.11.1 Novamont Corporation Information
12.11.2 Novamont Overview
12.11.3 Novamont Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Novamont Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Novamont Recent Developments
12.12 DSM
12.12.1 DSM Corporation Information
12.12.2 DSM Overview
12.12.3 DSM Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 DSM Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 DSM Recent Developments
12.13 Braskem
12.13.1 Braskem Corporation Information
12.13.2 Braskem Overview
12.13.3 Braskem Medical Bioplastic Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Braskem Medical Bioplastic Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Braskem Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Medical Bioplastic Industry Chain Analysis
13.2 Medical Bioplastic Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Medical Bioplastic Production Mode & Process
13.4 Medical Bioplastic Sales and Marketing
13.4.1 Medical Bioplastic Sales Channels
13.4.2 Medical Bioplastic Distributors
13.5 Medical Bioplastic Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Medical Bioplastic Industry Trends
14.2 Medical Bioplastic Market Drivers
14.3 Medical Bioplastic Market Challenges
14.4 Medical Bioplastic Market Restraints
15 Key Finding in The Global Medical Bioplastic Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer